Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21773496 | 1.00 | CYP2D6 (0.34) | CYP2D6CYP2C19 | |
| SCHEMBL21773508 | 0.83 | CYP2D6 (0.32) | CYP2D6CYP2C19 | |
| SCHEMBL20488841 | 0.83 | CYP2D6 (0.32) | CYP2D6CYP2C19 | |
| SCHEMBL21791605 | 0.79 | MEN1 (0.36) | CYP2D6 | |
| SCHEMBL28351352 | 0.79 | MEN1 (0.36) | CYP2D6 | |
| SCHEMBL2923217 | 0.70 | CYP2D6 (0.30) | CYP2D6CYP2C19 | |
| SCHEMBL2923221 | 0.70 | CYP2D6 (0.30) | CYP2D6CYP2C19 | |
| SCHEMBL21814722 | 0.70 | CYP2D6 (0.30) | CYP2D6CYP2C19 | |
| SCHEMBL21773561 | 0.69 | ALOX15 (0.31) | — | |
| SCHEMBL20489148 | 0.69 | ALOX15 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200069648-A1 | HALOALLYLAMINE PYRAZOLE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF | PHARMAXIS LTD. (AU) | 2020-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200069648-A1 | HALOALLYLAMINE PYRAZOLE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF | LOX, DAO, AADAC | CYP2D6 1240/4885CYP2C19 465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.